The endoplasmic reticulum stress response in prostate cancer

CM de la Calle, K Shee, H Yang, PE Lonergan… - Nature Reviews …, 2022 - nature.com
In order to proliferate in unfavourable conditions, cancer cells can take advantage of the
naturally occurring endoplasmic reticulum-associated unfolded protein response (UPR) via …

Regulation of endoplasmic reticulum stress by hesperetin: Focus on antitumor and cytoprotective effects

Y Hussain, H Khan, T Efferth, W Alam - Phytomedicine, 2022 - Elsevier
Background Cancer is still an all-times issue due to a large and even increasing number of
deaths. Impaired genes regulating cell proliferation and apoptosis are targets for the …

Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer

A Urbanucci, SJ Barfeld, V Kytölä, HM Itkonen… - Cell reports, 2017 - cell.com
Global changes in chromatin accessibility may drive cancer progression by reprogramming
transcription factor (TF) binding. In addition, histone acetylation readers such as …

[HTML][HTML] Antitumor activity of alkylphospholipid edelfosine in prostate cancer models and endoplasmic reticulum targeting

ELH Dakir, C Gajate, F Mollinedo - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Prostate cancer is the second most frequent cancer and the fifth leading cause of cancer
death among men worldwide. While the five-year survival in local and regional prostate …

1, 25 (OH) 2 D3 induced vitamin D receptor signaling negatively regulates endoplasmic reticulum-associated degradation (ERAD) and androgen receptor signaling in …

Y Erzurumlu, E Aydogdu, HK Dogan, D Catakli… - Cellular …, 2023 - Elsevier
Steroid hormone signaling is critical in the tumor progression and the regulation of
physiological mechanisms such as endoplasmic reticulum-associated degradation (ERAD) …

Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer

A Naiki-Ito, T Naiki, H Kato, K Iida, T Etani… - …, 2020 - academic.oup.com
A need exists for seeking effective treatments for castration-resistant prostate cancer (CRPC)
in response to its emergence following androgen deprivation therapy as a major clinical …

HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation

C Zeng, J Guo, J Wu, T Che, X Huang, H Liu… - Journal of Biological …, 2023 - ASBMB
Dysregulation of autophagy has been implicated in the development of many diseases,
including cancer. Here, we revealed a novel function of the E3 ubiquitin ligase HRD1 in non …

Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells

Y Erzurumlu, D Catakli, HK Dogan - Journal of Natural Medicines, 2023 - Springer
Prostate cancer (PCa) is the second most common type of cancer and the sixth cause of
death in men worldwide. Radiotherapy and immunotherapy are commonly used in treating …

Proteomic analysis of holocarboxylase synthetase deficient-MDA-MB-231 breast cancer cells revealed the biochemical changes associated with cell death, impaired …

W Sukjoi, C Young, M Acland… - Frontiers in Molecular …, 2024 - frontiersin.org
We have previously shown that the holocarboxylase synthetase (HLCS) is overexpressed in
breast cancer tissue of patients, and silencing of its expression in triple-negative cancer cell …

Targeting genotoxic and proteotoxic stress‐response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram

D Majera, Z Skrott, J Bouchal, J Bartkova… - The …, 2019 - Wiley Online Library
Background Castration‐resistant prostate cancer (PCa) represents a serious health
challenge. Based on mechanistically‐supported rationale we explored new therapeutic …